<code id='A1DBDEF88F'></code><style id='A1DBDEF88F'></style>
    • <acronym id='A1DBDEF88F'></acronym>
      <center id='A1DBDEF88F'><center id='A1DBDEF88F'><tfoot id='A1DBDEF88F'></tfoot></center><abbr id='A1DBDEF88F'><dir id='A1DBDEF88F'><tfoot id='A1DBDEF88F'></tfoot><noframes id='A1DBDEF88F'>

    • <optgroup id='A1DBDEF88F'><strike id='A1DBDEF88F'><sup id='A1DBDEF88F'></sup></strike><code id='A1DBDEF88F'></code></optgroup>
        1. <b id='A1DBDEF88F'><label id='A1DBDEF88F'><select id='A1DBDEF88F'><dt id='A1DBDEF88F'><span id='A1DBDEF88F'></span></dt></select></label></b><u id='A1DBDEF88F'></u>
          <i id='A1DBDEF88F'><strike id='A1DBDEF88F'><tt id='A1DBDEF88F'><pre id='A1DBDEF88F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:5
          The sign of Optum, an American health care company, on the top of its light brown building under the blue sky — first opinion coverage from STAT
          Emanate Health sued UnitedHealth's Optum, alleging the insurer pushed it to agree not to compete for primary care physicians, a violation of antitrust law. Adobe

          UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States, but allegations in a new lawsuit suggest Optum is hungry for more.

          Emanate Health, a nonprofit group of hospitals and physicians in California, filed a federal lawsuit Monday, alleging Optum pushed it to agree not to compete for primary care physicians, a violation of antitrust law. When the health system refused, Emanate said in its complaint, Optum cut off contracts and steered patients to other providers.

          advertisement

          UnitedHealth’s Optum subsidiary, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, has been especially focused on acquiring provider practices in recent years. It employs or is affiliated with 70,000 physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA panel gives mixed vote on blood pressure devices
          FDA panel gives mixed vote on blood pressure devices

          AdobeAnadvisorypaneltotheFoodandDrugAdministrationdeliveredasplitdecisiononasurgicalsystemusedinacon

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Readout Newsletter: CAR

          HyacinthEmpinado/STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote